EGFR and breast carcinoma: We engineered BT20 and MDA-MB-468 (human EGFR+ breast cancer cell lines) cells with control shRNA (targeted to firefly luciferase) or shRNA targeted to HUNK (HUNK shRNA1 and shRNA2) (Fig. 2a and Supplementary Fig. 2a).